Other

US wants more information from Roche on Illumina bid

Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.

Diseases, Conditions, Syndromes

Czechs close borders from March 16 over virus spread

The Czech government said Friday it would ban all foreign travellers from entering and all Czechs from leaving the country as of March 16 in a bid to stem the coronavirus spread.

Medications

AstraZeneca doubles profits; warns of lower drug sales

British pharmaceuticals giant AstraZeneca on Thursday said its net profits more than doubled in 2015, adding it expects lower sales this year on US patent expiry of cholesterol treatment Crestor.

Other

Depomed rejects Horizon's latest takeover offer

Depomed Inc. on Monday rejected Horizon Pharma PLC's sweetened $2.4 billion hostile takeover offer, saying it still undervalues the company, and recommended that its shareholders reject the bid.

Medications

Roche extends its hostile takeover bid for Illumina

Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.

Diseases, Conditions, Syndromes

Denmark closes borders to foreigners: official

Denmark will close its borders to foreigners from Saturday midday, (1100 GMT) in a bid to slow the advance of coronavirus, Prime Minister Mette Frederiksen said Friday.

Other

Takeda hikes Shire takeover bid to almost $61 bn

Japanese drugs firm Takeda on Friday upped its takeover bid to $60.7 billion (49 billion euros) for Irish-based peer Shire, which has already rejected its previous three overtures.

page 2 from 5